← Back to Explore

Biocompatibility and Radioprotective Activity of Squid Ink-Derived Nanomelanin on Human Umbilical Cord-Derived Mesenchymal Stem Cells

ISEF · 2023 Biomedical and Health Sciences

Overview

Squid ink–derived nanomelanin has recently demonstrated the radiation protective capacity on the spleen of gamma ray-irradiated mice and X-ray irradiated keratinocyte HaCaT. In this study, we aimed to evaluate the protective activity of this nanoparticle on human umbilical cord-derived mesenchymal stem cells (UCMSCs), the key players in the recovery of damaged tissue after exposure to irradiation. The results showed that nanomelanin had a high biocompatibility with low cytotoxicity, an IC50 of 74,1±2,4 ug/mL, no cell senescence induction, and no effect on cell differentiation. Besides, nanomelanin nanoparticles showed a minimum effect on the migration of UCMSCs. Additionally, the expressions of functional genes involved in angiogenesis, apoptosis, antioxidant, and radiation sensitivity were not affected by nanomelanin in this cell type. X-ray radiation reduced the cell viability at the dose of 7 Gy and altered the functional gene expression in UCMSCs at 5 Gy. Interestingly, nanomelanin significantly rescued the cell viability and recovered the gene expression of UCMSCs from such irradiation. Furthermore, in vivo treatments on zebrafish embryos showed that nanomelanin was non-toxic with LC50 and EC50 values were 205.3 and 204.1 ug/mL. These findings suggested nanomized squid ink melanin as a radiation-protective agent on stromal cells. Keywords: Melanin, nanomelanin, radioactive protection, mesenchymal stem cells, angiogenesis

Competition history

  • ISEF 2023 Biomedical and Health Sciences · Entry BMED059T · Dallas, Texas, United States

Resources

Related projects

Closest projects by meaning, across every fair and year in the corpus.

Source: Regeneron International Science and Engineering Fair

Save projects to your library

Sign in with Google to keep track of projects you find interesting, organized into folders. Browsing stays public.

Continue with Google